Clinical trials
Rhabdomyosarcoma trials with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2011 | 2 |
| 2012 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2018 | 1 |
| 2025 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 7 |
| Recruiting | 2 |
| Active, not recruiting | 1 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| St. Jude Children's Research Hospital | 3 |
| Ann & Robert H Lurie Children's Hospital of Chicago | 1 |
| Children's Hospitals and Clinics of Minnesota | 1 |
| Dana-Farber Cancer Institute | 1 |
| Giselle Sholler | 1 |
| Institut Curie | 1 |
| Masonic Cancer Center, University of Minnesota | 1 |
| Massachusetts General Hospital | 1 |
| Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Rhabdomyosarcoma | 11 |
| Sarcoma, Ewing | 7 |
| Osteosarcoma | 6 |
| Sarcoma | 6 |
| Medulloblastoma | 3 |
| Wilms Tumor | 3 |
| Brain Neoplasms | 2 |
| Carcinoma, Renal Cell | 2 |
| Central Nervous System Neoplasms | 2 |
| Neoplasms, Germ Cell and Embryonal | 2 |
Trials
Showing 26 to 11 of 11. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.